Migration of implanted markers for image‐guided lung tumor stereotactic ablative radiotherapy

Julian C. Hong, Neville Eclov, Yao Yu, Aarti K. Rao, Sonja Dieterich, Quynh‐Thu Le, Maximilian Diehn, Daniel Y. Sze, Billy W. Loo, Nishita Kothary, Peter G. MaximJournal of Applied Clinical Medical Physics 2013 · DOI

TL;DR

This study quantifies the migration of implanted gold seeds and platinum coils used as fiducial markers for lung cancer radiotherapy. The findings suggest that marker migration between implantation and treatment planning CT scans is minimal (median 1.28 mm), indicating that these markers are reliable for image-guided treatments and that current planning margins are likely sufficient.

What Problem Does This Paper Address?

Stereotactic ablative radiotherapy (SABR) for lung tumors requires precise targeting, which is challenging due to the motion of lung lesions during respiration. Image-guided radiation therapy (IGRT) techniques often rely on radiopaque fiducial markers implanted near the tumor to improve localization. However, the stability of these markers over time is crucial; if they migrate significantly between implantation and treatment planning, it could lead to inaccurate targeting, potentially under-treating the tumor or over-treating healthy tissue. This paper addresses the question of how much these implanted markers migrate in the lung between the time they are placed and when the treatment plan is finalized.

Methods

The researchers retrospectively analyzed CT scans from 32 patients who had undergone implantation of either gold seeds or platinum coils as fiducial markers. They compared marker positions from post-implantation CT scans to those taken during treatment planning CT scans. To quantify marker migration, they employed a method to minimize the "fiducial registration error" (FRE), which is essentially the root-mean-square difference in marker positions between the two scans.

A key methodological innovation was the development of an "outlier identification" process. This involved calculating the optimal rigid transformation (alignment) of markers, first considering all markers and then iteratively excluding one marker at a time to see if excluding a specific "outlier" marker significantly improved the alignment and reduced the FRE. This approach aimed to isolate the contribution of individual markers that might be responsible for a disproportionate amount of the observed migration. The transformation was then applied to all markers to determine the overall migration.

Datasets

The study utilized retrospective CT scan data from 32 patients who underwent fiducial marker placement for pulmonary tumors. A total of 147 markers (59 seeds and 88 coils) were implanted in or around 34 lung lesions. The data included post-implantation CT scans and treatment planning CT scans. No new datasets were introduced.

Key Insights and Ideas

  • Outliers Drive Migration: The study found that a significant portion of the observed marker migration could often be attributed to a single "outlier" marker. When these outliers were excluded, the migration of the remaining markers was considerably reduced. This suggests that most markers remain stable, but occasional outliers can skew the overall migration assessment.
  • Minimal Overall Migration: Even when considering all markers, the median migration was relatively small (1.28 mm for individual markers, 1.56 mm for lesion FRE). This indicates that for lung SABR, the time between marker implantation and treatment planning (typically around 8 days in this study) does not lead to substantial marker displacement.
  • Marker Type Doesn't Matter (Much): The study found no statistically significant difference in migration between gold seeds and platinum coils. While coils had a slightly higher retention rate, their migration characteristics were comparable to seeds.
  • Planning Margins Likely Sufficient: The observed migration, especially after accounting for outliers, is small enough that it's unlikely to cause a geometric miss during tracking, suggesting that current treatment planning margins are adequate.

Key Results

  • Median individual marker migration: 1.28 mm (IQR 0.78-2.63 mm).
  • Median lesion FRE (without outlier identification): 1.56 mm (IQR 0.92-2.95 mm).
  • Median lesion FRE (with outlier identification): 1.97 mm (IQR 1.44-4.32 mm).
  • Median individual marker migration (after outlier identification): 1.03 mm (IQR 0.52-2.21 mm).
  • Center of mass shift due to outliers: Mean of 1.22 mm, median of 0.80 mm.
  • No significant difference in migration between seeds and coils.
  • No correlation found between migration and number of markers, contact with the chest wall, or time elapsed between scans.

Limitations and Future Work

  • Breathing Phase Differences: The study acknowledges that the postimplantation scans were acquired during free breathing, while treatment planning scans were often acquired during expiration breath-hold. This difference in breathing phase could introduce some error in the migration measurements.
  • CT Resolution: The 5 mm slice thickness of the postimplantation CT scans might limit the ability to resolve very small migrations.
  • Lesion Deformation: While the study aimed to account for gross motion, small deformations of the lung lesion or surrounding parenchyma due to breathing could also contribute to apparent migration.
  • Future Work: The authors suggest that a logical next step would be to analyze marker migration during the course of radiotherapy, using daily or weekly cone-beam CT scans to compare marker positions to the initial simulation. This would provide a more direct assessment of marker stability throughout the treatment period.

Summary updated

Abstract

The purpose of this study was to quantify postimplantation migration of percutaneously implanted cylindrical gold seeds ("seeds") and platinum endovascular embolization coils ("coils") for tumor tracking in pulmonary stereotactic ablative radiotherapy (SABR). We retrospectively analyzed the migration of markers in 32 consecutive patients with computed tomography scans postimplantation and at simulation. We implanted 147 markers (59 seeds, 88 coils) in or around 34 pulmonary tumors over 32 procedures, with one lesion implanted twice. Marker coordinates were rigidly aligned by minimizing fiducial registration error (FRE), the root mean square of the differences in marker locations for each tumor between scans. To also evaluate whether single markers were responsible for most migration, we aligned with and without the outlier causing the largest FRE increase per tumor. We applied the resultant transformation to all markers. We evaluated migration of individual markers and FRE of each group. Median scan interval was 8 days. Median individual marker migration was 1.28 mm (interquartile range [IQR] 0.78-2.63 mm). Median lesion FRE was 1.56 mm (IQR 0.92-2.95 mm). Outlier identification yielded 1.03 mm median migration (IQR 0.52-2.21 mm) and 1.97 mm median FRE (IQR 1.44-4.32 mm). Outliers caused a mean and median shift in the centroid of 1.22 and 0.80 mm (95th percentile 2.52 mm). Seeds and coils had no statistically significant difference. Univariate analysis suggested no correlation of migration with the number of markers, contact with the chest wall, or time elapsed. Marker migration between implantation and simulation is limited and unlikely to cause geometric miss during tracking.
BibTeX
@article{hong2013migration,
  author = {Julian C. Hong and Neville Eclov and Yao Yu and Aarti K. Rao and Sonja Dieterich and Quynh‐Thu Le and Maximilian Diehn and Daniel Y. Sze and Billy W. Loo and Nishita Kothary and Peter G. Maxim},
  title = {{Migration of implanted markers for image‐guided lung tumor stereotactic ablative radiotherapy}},
  journal = {Journal of Applied Clinical Medical Physics},
  year = {2013},
  doi = {10.1120/jacmp.v14i2.4046},
}
Figure